On November 14, the 2026 edition of the National Health Insurance Catalogue was announced. Xiansheng Pharmaceutical's innovative stroke drug edaravone dexcamol sublingual tablets were included in the national medical insurance catalogue for the first time. The concentrated solution of edaravone dextroxol for injection completed the third medical insurance renewal, with a price reduction of 12%.

Zhitongcaijing · 1d ago
On November 14, the 2026 edition of the National Health Insurance Catalogue was announced. Xiansheng Pharmaceutical's innovative stroke drug edaravone dexcamol sublingual tablets were included in the national medical insurance catalogue for the first time. The concentrated solution of edaravone dextroxol for injection completed the third medical insurance renewal, with a price reduction of 12%.